Add to ORKG© 2014 The Authors Transplant International published by John Wiley & Sons Ltd on behalf of Steunstichting ESOT.Clinical data relating to rabbit antithymocyte globulin (rATG) induction in heart transplantation are far less extensive than for other immunos
Background. End-stage renal failure occurs in a substantial number of patients having received a non...
Thymoglobulin is a purified polyclonal immunoglobulin that has been used widely over the last decade...
BACKGROUND: In cardiac transplantation, high-dose antithymocyte globulin (ATG) induction therapy as ...
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance...
Background: Induction immunosuppression is used in transplantation to prevent early acute rejection....
BACKGROUND: The Thymoglobulin Antibody Immunosuppression in Living Donor Recipients registry was est...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract In the 3...
Pediatric heart transplantation (pHTx) represents only a small proportion of cardiac transplants. Du...
Heart transplantation (HTx) is a well-established treatment for end stage heart diseases. Rabbit ant...
Induction treatment with rabbit polyclonal antithymocyte globulins (ATGs) is frequent used in kidney...
Delayed graft function (DGF) increases the risk of graft loss by up to 40%, and recent developments ...
Induction treatment with rabbit polyclonal antithymocyte globulins (ATGs) is frequent used in kidney...
Work in progress report- Transplantation Induction immunosuppression after heart transplantation: mo...
AbstractThe most modifiable risk factor for post-transplant lymphoproliferative disease (PTLD) is th...
Leah Andress,1 Anjali Gupta,2 Nida Siddiqi,3 Kwaku Marfo2,3 1University at Buffalo School of Pharmac...
Background. End-stage renal failure occurs in a substantial number of patients having received a non...
Thymoglobulin is a purified polyclonal immunoglobulin that has been used widely over the last decade...
BACKGROUND: In cardiac transplantation, high-dose antithymocyte globulin (ATG) induction therapy as ...
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance...
Background: Induction immunosuppression is used in transplantation to prevent early acute rejection....
BACKGROUND: The Thymoglobulin Antibody Immunosuppression in Living Donor Recipients registry was est...
The Author(s) 2014. This article is published with open access at Springerlink.com Abstract In the 3...
Pediatric heart transplantation (pHTx) represents only a small proportion of cardiac transplants. Du...
Heart transplantation (HTx) is a well-established treatment for end stage heart diseases. Rabbit ant...
Induction treatment with rabbit polyclonal antithymocyte globulins (ATGs) is frequent used in kidney...
Delayed graft function (DGF) increases the risk of graft loss by up to 40%, and recent developments ...
Induction treatment with rabbit polyclonal antithymocyte globulins (ATGs) is frequent used in kidney...
Work in progress report- Transplantation Induction immunosuppression after heart transplantation: mo...
AbstractThe most modifiable risk factor for post-transplant lymphoproliferative disease (PTLD) is th...
Leah Andress,1 Anjali Gupta,2 Nida Siddiqi,3 Kwaku Marfo2,3 1University at Buffalo School of Pharmac...
Background. End-stage renal failure occurs in a substantial number of patients having received a non...
Thymoglobulin is a purified polyclonal immunoglobulin that has been used widely over the last decade...
BACKGROUND: In cardiac transplantation, high-dose antithymocyte globulin (ATG) induction therapy as ...